Using nationally representative data, the authors found that for common physician-administered drugs, hospitals’ unilaterally set cash prices are frequently lower than their median—and sometimes even ...

Objective: To determine whether industry payments to cardiologists are associated with Medicare beneficiary spending, as financial incentives may influence clinical deci ...

Axsome Therapeutics (NASDAQ:AXSM) executives provided updates on the company’s commercial portfolio and pipeline during a ...

The Medicare Advantage program allows private insurers to bundle everything together and offers many enrollment options. Compared with traditional Medicare, Medicare Advantage plans typically offer ...

Direct-to-consumer drug advertising has long been opposed by the American Medical Association — and now the Trump ...

Insurance and health record data showed about 3% of smokers with peripheral artery disease were prescribed the smoking cessation drug, despite the significant benefits of quitting.

Two Michigan health care giants are squaring off in an intensifying reimbursement battle. Michigan Medicine is seeking to maintain its place as the preeminent academic health system in the state with ...

In 2019, BMS made a big bet on Sotyktu by deciding to keep the then-pipeline asset despite its pending acquisition of Celgene. Based on that decision, BMS sold its mega-blockbuster Otezla to Amgen for ...

Payer relations executives to know in 2026 are shaping managed care strategies at major health systems and advancing value-based payment models.

CFO Mark Kaye will expand responsibilities as executive vice president as Carelon President Peter D. Haytaian transitions to ...

Officials and policymakers say direct-to-consumer drug advertising encourages patients to seek treatments they don’t need and ...

Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), the nation’s largest providers of end-of-life care, and Roto-Rooter, the nation’s largest commercial and ...